Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial.
Krucoff M, Spirito A, Baber U, Sartori S, Angiolillo DJ, Briguori C, Cohen DJ, Collier T, Dangas G, Dudek D, Escaned J, Gibson CM, Han YL, Huber K, Kastrati A, Kaul U, Kornowski R, Kunadian V, Vogel B, Mehta SR, Moliterno D, Sardella G, Shlofmitz RA, Sharma S, Steg PG, Pocock S, Mehran R. Krucoff M, et al. Among authors: moliterno d. Am Heart J. 2024 Jun;272:11-22. doi: 10.1016/j.ahj.2024.03.002. Epub 2024 Mar 6. Am Heart J. 2024. PMID: 38458371 Clinical Trial.
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial.
Moliterno DJ; TENACITY Steering Committee and Investigators. Moliterno DJ, et al. Catheter Cardiovasc Interv. 2011 Jun 1;77(7):1001-9. doi: 10.1002/ccd.22876. Epub 2011 Jan 11. Catheter Cardiovasc Interv. 2011. PMID: 21598351 Clinical Trial.
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention.
Angiolillo DJ, Cao D, Sartori S, Baber U, Dangas G, Zhang Z, Vogel B, Kunadian V, Briguori C, Cohen DJ, Collier T, Dudek D, Gibson M, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Ielasi A, Stefanini GG, Pivato CA, Mehta S, Moliterno DJ, Ohman EM, Escaned J, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Steg PG, Pocock S, Mehran R. Angiolillo DJ, et al. Among authors: moliterno dj. JACC Cardiovasc Interv. 2023 Oct 23;16(20):2514-2524. doi: 10.1016/j.jcin.2023.08.019. JACC Cardiovasc Interv. 2023. PMID: 37879803 Clinical Trial.
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial.
Baber U, Spirito A, Sartori S, Angiolillo DJ, Briguori C, Cohen DJ, Collier T, Dangas G, Dudek D, Escaned J, Gibson CM, Han YL, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Vogel B, Mehta SR, Moliterno D, Sardella G, Shlofmitz RA, Sharma S, Steg PG, Pocock S, Mehran R. Baber U, et al. Among authors: moliterno d. Am J Cardiol. 2023 Dec 1;208:16-24. doi: 10.1016/j.amjcard.2023.09.008. Epub 2023 Oct 6. Am J Cardiol. 2023. PMID: 37806185 Clinical Trial.
Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions.
Mendieta G, Mehta S, Baber U, Angiolillo DJ, Briguori C, Cohen D, Collier T, Dangas G, Dudek D, Escaned J, Gil R, Vogel B, Cao D, Spirito A, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff MW, Kunadian V, Moliterno DJ, Ohman EM, Sardella G, Sartori S, Sharma S, Shlofmitz R, Steg PG, Han YL, Pocock S, Gibson CM, Mehran R. Mendieta G, et al. Among authors: moliterno dj. J Am Coll Cardiol. 2023 Aug 22;82(8):687-700. doi: 10.1016/j.jacc.2023.05.062. J Am Coll Cardiol. 2023. PMID: 37587580 Clinical Trial.
JACC Journals' Pathway Forward With AI Tools: The Future Is Now.
Fuster V, Bozkurt B, Chandrashekhar Y, Grapsa J, Ky B, Mann DL, Moliterno DJ, Shivkumar K, Silversides CK, Turco JV, Wang J. Fuster V, et al. Among authors: moliterno dj. JACC Basic Transl Sci. 2023 Mar 17;8(5):596-598. doi: 10.1016/j.jacbts.2023.03.005. eCollection 2023 May. JACC Basic Transl Sci. 2023. PMID: 37325406 Free PMC article. No abstract available.
JACC Journals' Pathway Forward With AI Tools: The Future Is Now.
Fuster V, Bozkurt B, Chandrashekhar Y, Grapsa J, Ky B, Mann DL, Moliterno DJ, Shivkumar K, Silversides CK, Turco JV, Wang J. Fuster V, et al. Among authors: moliterno dj. JACC Asia. 2023 Mar 17;3(2):317-319. doi: 10.1016/j.jacasi.2023.03.002. eCollection 2023 Apr. JACC Asia. 2023. PMID: 37181383 Free PMC article. No abstract available.
404 results